BJA Advance Access published online on June 25, 2004
British Journal of Anaesthesia, doi:10.1093/bja/aeh219
© 2004 by The Board of Management and Trustees of the British Journal of Anaesthesia
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Anaesthesia, Rotunda Hospital, Parnell Square, Dublin 1, Ireland; Department of Anaesthesia, St Mary's NHS Trust, Praed St, London W2 1NY, UK
* To whom correspondence should be addressed. E-mail: jjmagner{at}irishanaesthesia.com.
Background. I.V. fluid administration has been shown to reduce postoperative nausea and vomiting (PONV). The optimum dose is unknown. We tested the hypothesis that administration of i.v. crystalloid of 30 ml kg-1 would reduce the incidence of PONV compared with 10 ml kg-1 of the same fluid. Methods. A total of 141 ASA I female patients undergoing elective gynaecological laparoscopy were randomized, in double-blind fashion, to receive either 10 ml kg-1 (n=71; CSL-10 group) or 30 ml kg-1 (n=70; CSL-30 group) of i.v. compound sodium lactate (CSL). Results. In the first 48 h after anaesthesia, the incidence of vomiting was lower in the CSL-30 group than in the CSL-10 group (8.6% vs 25.7%, P=0.01). Anti-emetic use was less in the CSL-30 group at 0.5 h (2.9% vs 14.3%, P=0.04). The incidence of severe nausea was significantly reduced in the treatment group at awakening (2.9% vs 15.7%, P=0.02), 2 h (0.0% vs 8.6%, P=0.04) and cumulatively (5.7% vs 27.1%, P=0.001). The numbers needed to treat to prevent vomiting, severe nausea and antiemetic use in the first 48 h were 6, 5 and 6, respectively. Conclusion. I.V. administration of CSL 30 ml kg-1 to healthy women undergoing day-case gynaecological laparoscopy reduced the incidence of vomiting, nausea and anti-emetic use when compared with CSL 10 ml kg-1.
Clinical Investigation
Effect of intraoperative intravenous crystalloid infusion on postoperative nausea and vomiting after gynaecological laparoscopy: comparison of 30 and 10 ml kg-1
2 Divisions of Anaesthesia, Intensive Care Medicine and The Lung Biology Programme, The Hospital For Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada
3 Department of Anaesthesia, Rotunda Hospital, Parnell Square, Dublin 1, Ireland; Department of Anaesthesia and Intensive Care Medicine, Mater Misericordiae Hospital, Eccles St, Dublin 7, Ireland
4 Department of Anaesthesia and Intensive Care Medicine, Mater Misericordiae Hospital, Eccles St, Dublin 7, Ireland
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. L. Haentjens, D. Ghoundiwal, K. Touhiri, M. Renard, E. Engelman, V. Anaf, P. Simon, L. Barvais, and B. E. Ickx Does Infusion of Colloid Influence the Occurrence of Postoperative Nausea and Vomiting After Elective Surgery in Women? Anesth. Analg., June 1, 2009; 108(6): 1788 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. White, H. Kehlet, J. M. Neal, T. Schricker, D. B. Carr, F. Carli, and the Fast-Track Surgery Study Group The Role of the Anesthesiologist in Fast-Track Surgery: From Multimodal Analgesia to Perioperative Medical Care Anesth. Analg., June 1, 2007; 104(6): 1380 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tominaga and T. Nakahara The Twenty-Degree Reverse-Trendelenburg Position Decreases the Incidence and Severity of Postoperative Nausea and Vomiting After Thyroid Surgery Anesth. Analg., November 1, 2006; 103(5): 1260 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. White, J. Tang, M. A. Hamza, B. Ogunnaike, M. Lo, R. H. Wender, R. Naruse, A. Sloninsky, R. Kariger, S. Cunneen, et al. The use of oral granisetron versus intravenous ondansetron for antiemetic prophylaxis in patients undergoing laparoscopic surgery: the effect on emetic symptoms and quality of recovery. Anesth. Analg., May 1, 2006; 102(5): 1387 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kabon, O. Akca, A. Taguchi, A. Nagele, R. Jebadurai, C. F. Arkilic, N. Sharma, A. Ahluwalia, S. Galandiuk, J. Fleshman, et al. Supplemental Intravenous Crystalloid Administration Does Not Reduce the Risk of Surgical Wound Infection Anesth. Analg., November 1, 2005; 101(5): 1546 - 1553. [Abstract] [Full Text] [PDF] |
||||
